Medicine
Cefazolin 1 g powder for injection
Cefazolin 1 g powder for injection is a generic prescription medicine for intramuscular, intravenous use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
NDC 60505-6243-4, 1 gram, carton of 25 vials As with other cephalosporins…
Key facts
- Active ingredient (INN)
- Cefazolin
- Brand
- Sold under the generic name
- Strength
- 1 g
- Dosage form
- Powder for injection
- Route
- Intramuscular, intravenous
- Packs
- 25 vials, 1 injection, 1 vial and 8 more
- Manufacturers
- ApotexWG Critical CareCivicaDirect_RxHenry ScheinMedical Purchasing SolutionsProficient RxProPharma DistributionQilu Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- NDC 60505-6243-4, 1 gram, carton of 25 vials As with other cephalosporins, cefazolin tends to darken depending on storage conditions, within the stated recommendations, however, product potency is not adversely affected. Before reconstitution protect from light and store at 20° to 25° C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DB04 Cefazolin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 March 2015
- Identifiers
- RxCUI 1665050, 1665052, 1665060 +1DailyMed set ID 37a626aa-96dc-4c4d-bfbc-be4f328f918b, f17160d4-fc42-4f9c-abb8-d04f01ae6dd1, e8bd9e95-8af5-416b-b58c-e1dbe3d052ac +8NDC 60505-6243, 44567-707, 67184-1001 +8Application ANDA203661, ANDA065303, ANDA065047
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose | 60505-6142-5 | Apotex | 30 June 2017 |
| 25 vial, single-dose in 1 carton / 1 injection, powder, for solution in 1 vial, single-dose | 60505-6243-4 | Apotex | 1 September 2022 |
| 25 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 44567-120-25 | WG Critical Care | 23 April 2019 |
| 25 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 44567-707-25 | WG Critical Care | 6 March 2015 |
| 25 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 67184-1001-2 | Qilu Pharmaceutical | 28 December 2015 |
| 25 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 72572-055-25 | Civica | 1 March 2022 |
| 1 injection, powder, for solution in 1 carton | 72189-584-01 | Direct_rx | 24 September 2024 |
| 1 vial, single-dose in 1 bag / 1 injection, powder, for solution in 1 vial, single-dose | 0404-9833-99 | Henry Schein | 9 January 2022 |
| 1 vial, single-dose in 1 bag / 1 injection, powder, for solution in 1 vial, single-dose | 71872-7141-1 | Medical Purchasing Solutions | 13 July 2018 |
| 1 vial, single-dose in 1 box / 1 injection, powder, for solution in 1 vial, single-dose | 71205-679-01 | Proficient Rx | 1 August 2022 |
| 1 injection, powder, for solution in 1 vial, single-dose | 84549-142-05 | ProPharma Distribution | 1 September 2025 |
| 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 0781-3451-95 | — | 5 January 2026 |
| 25 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 0781-3451-96 | — | 9 December 1988 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 October 1973 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Cefazolin 1 g powder for injection.
Other strengths and forms of Cefazolin
Clinical summary
Cefazolin is a cephalosporin antibacterial indicated for treatment of infections caused by susceptible isolates of the designated microorganisms in adult and pediatric patients for whom appropriate dosing with this formulation can be achieved, among other approved uses. MedsAcross supplies Cefazolin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefazolinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cefazolin Sodium prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Cefazolin 1 g powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.